Thursday, November 14, 2019
For the first time the President of ASCO gave a lecture to our oncologists
Thoughts of ASCO President 2009-2010. Prof.D.Blayney.
Clinical trials. System within the system. Prof. Igor Bondarenko
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
Important links for students
Вы можете просмотреть эту страницу на